YD Bio Limited Warrants (YDESW) Stock Analysis

What YD Bio Limited Warrants does

YD Bio Limited specializes in pioneering diagnostic and therapeutic technologies. Its offerings encompass oncology screening solutions, regenerative treatments for ophthalmology, and advancements in exosome research. Established on February 6, 2024, the firm is based in Taipei, Taiwan.

Key metrics

ETFs linked to YDESW

Broad-market and Healthcare sector ETFs an investor holding YD Bio Limited Warrants is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how YDESW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for YD Bio Limited Warrants?

YD Bio Limited Warrants trades under the ticker YDESW on NASDAQ.

Which exchange is YDESW listed on?

YDESW is listed on NASDAQ.

What sector does YD Bio Limited Warrants operate in?

YD Bio Limited Warrants is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze YDESW in a portfolio?

PortView shows YDESW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.